Galecto, Inc. (DMRA) vs Replimune Group, Inc. (REPL)
- Galecto, Inc. DMRA 18.42 −1.71%
- Replimune Group, Inc. REPL 10.86 −7.57%
Galecto, Inc. and Replimune Group, Inc. are both Biotechnology companies. Galecto, Inc. and Replimune Group, Inc. are of similar size ($1.2B and $1.1B). Across the 10 metrics below, Galecto, Inc. leads on 7 and Replimune Group, Inc. on 3.
Valuation
Profitability
| Metric | DMRA | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (26.26%) | (134.29%) | (56.36%) |
| Return on assets | (18.64%) | (82.28%) | (48.04%) |
| Return on invested capital | 0.00% | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack